Healthcare >> Analyst Interviews >> September 6, 2004

SPECIALTY PHARMACEUTICALS & DRUG DELIVERY: LOUIS WEBB – WR HAMBRECHT & CO

LOUIS WEBB joined WR Hambrecht + Co at the end of 2002 as a Managing Director and Senior Analyst focusing on specialty pharmaceuticals. Prior to joining WR Hambrecht + Co, he served as a Director in the Research Department of RBC Capital Markets covering specialty pharmaceuticals. His 27 years of experience covering the pharmaceutical sector also include tenures at Fahnestock & Co. and Robert W. Baird & Co. He is also a two-time first place winner of The Wall Street Journal annual analyst survey for stock picking and earnings accuracy. Mr. Webb received a Bachelor of Science degree in Engineering and Applied Science from Yale University in 1975 and became a Chartered Financial Analyst in 1980. Profile
TWST: Would you begin with an overview of your pharmaceutical coverage?

Mr. Webb: At WR Hambrecht my research coverage centers on specialty

pharmaceutical companies. This sector develops and